Pfizer CEO Albert Bourla tested positive for COVID-19

Albert Bourla, CEO of Pfizer Inc., tested positive for COVID-19. He tweeted on Monday that he received four shots of the COVID-19 vaccine developed by his company in collaboration with BioNTech SE. Pfizer CEO said that he is “experiencing very mild symptoms,” and that he has begun taking Paxlovid, Pfizer’s COVID-19 antiviral.

Press Release

NEW YORK, AUGUST 15, 2022 – Pfizer Inc. (NYSE: PFE) – I would like to inform the public that I have tested positive for COVID-19. I am grateful to have received four doses of the Pfizer-BioNTech vaccine and I am feeling well while experiencing very mild symptoms. I have started a course of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), I am isolating in place as well as following all public health precautions.

We have come so far in the past two years in our efforts to battle this disease that I am confident that I will have a speedy recovery. I am incredibly grateful for the tireless efforts of my Pfizer colleagues who worked to make vaccines and treatments available for me and people around the world

Share This Article
Brendan Taylor serves as the Breaking News Editor at Insider Paper, leading coverage of major developing stories, global events, and fast-moving news. With more than five and a half years of experience as a television news producer, he brings a strong understanding of newsroom operations, editorial judgment, and the demands of real-time reporting.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *